Cognixion is recruiting adults with ALS for a clinical trial testing BCI headset ONE Axon-R as a communication aid.

an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe to be used with central nervous system PET ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

For college athletes with concussion, brain changes may remain visible in brain scans up to a year after they are cleared to return to play, according to a study published online in Neurology.

But the groundwork is being laid now. Various groups have demonstrated the ability to decode certain kinds of thoughts, particularly what people are looking at, based on functional MRI brain scan ...

powered brain-computer interface (BCI) device developed by US-based startup Cognixion has now entered a crucial patient trial. Ten patients with amyotrophic lateral sclerosis (ALS) will train with ...

The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis (ALS ... EEG non-invasive brain sensing technologies ...

For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...